Advancing Cardiovascular Care

Live Cases (accessible only to ACC24 registrants)

Saturday, April 6

11 a.m.  – 12:15 p.m.
Peripheral Artery Disease Case
Matthew Bunte, MD

3:15 – 4:30 p.m.
Complex Coronary Artery Disease Case
Aaron Grantham, MD

All Saint Luke's Presentations

Saturday, April 6

9:30 – 9:40 a.m.
Sex Differences in Trends and Outcomes of Mechanical Complications From Acute Myocardial Infarction in the United States
Jonathan R. Enriquez, MD

10 – 10:10 a.m.
Should Our Patients Pay for Parking? A Simulation of Costs After Heart Transplantation
Andrew Sauer, MD

10:45 – 11:30 a.m.
Patient Perceptions Before and After Stress Nuclear Myocardial Perfusion Imaging 
Timothy M. Bateman, MD

11:45 a.m. – 12:30 p.m.
Walking Time to Closest Public Automated External Defibrillator for Out-of-Hospital Cardiac Arrest in a Major City
Mirza S. Khan, MD; Paul S. Chan, MD

1:45 – 1:55 p.m.
CPR and AED Availability: It Mattered to Me More Than You Might Know
Paul S. Chan, MD

2:03 – 2:11 p.m.
Debate Pro: Cardiac Imaging Reports Should Be Restructured to Minimize Technical Verbiage
John A. Spertus, MD

2:45 – 3:30 p.m.
Trends in Author Counts in Major General Cardiology Journals from 1980 to 2022
Mirza S. Khan, MD; Paul S. Chan, MD; John A. Spertus, MD

2:45 – 3:30 p.m.
A Difficult Case of Spontaneous Coronary Artery Dissection: A Case Report & Review
Ali Malik, MD

3:30 – 3:40 p.m.
Metabolic Effects of Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
Shachi Patel; Andrew Sauer, MD; Philip Jones; Sheryl L. Windsor; Mikhail Kosiborod, MD

3:45 – 3:55 p.m.
The Effect of Dapagliflozin on Days of Full Health Lost Due to Death, Hospitalization, and Impaired Well-Being in DAPA-HF
Mikhail Kosiborod, MD

3:45 – 3:55 p.m.
Neighborhood Health Predicts Peripheral Artery Disease Outcomes After Controlling for Quality of Medical Care: A Cohort Analysis Applying the Area Deprivation Index
Matthew C. Bunte, MD; Zhuxuan Fu; Philip Jones; Stacy L. Farr; Paul S. Chan, MD; John A. Spertus, MD

4:15 – 4:25 p.m.
Dapagliflozin in Patients with Heart Failure Across a Range of Left Ventricular Hypertrophy in the DELIVER Trial
Mikhail Kosiborod, MD

4:21 – 4:35 p.m.
SGLT2i or GLP1RA: Who's on First?
Mikhail Kosiborod, MD

5:17 – 5:25 p.m.
OPTIMUM: What I Learned About PCI In Surgical Turndown Patients
James Aaron Grantham, MD

Sunday, April 7

9:02 – 9:10 a.m.
Building a Comprehensive Vascular Program For Your Community
Matthew C. Bunte, MD

9:15 – 10 a.m.
Some Heart Breaks Are Worse Than Others: A Rare Case of Mid-Ventricular Takotsubo Cardiomyopathy Resulting in Cardiogenic Shock in Context of MDMA Use
Raul Angel Garcia, MD; Taiyeb M. Khumri, MD

10:15 – 10:25 a.m.
Regional Variation in Quadruple Medical Therapy at Discharge for Patients with Heart Failure Hospitalization: A Report from the IMPLEMENT-HF National Initiative 
Andrew Sauer, MD; John A. Spertus, MD

10:15 – 11 a.m.
Refractory Pleomorphic Ventricular Tachycardia Associated with Giant Cell Myocarditis
Raul Angel Garcia, MD; Sanjaya K. Gupta, MD

10:21 – 10:31 a.m.
Sex Differences in Spontaneous Coronary Artery Dissection: A Report of the ISCAD Registry
Anna Grodzinsky, MD

12:15 – 1 p.m.
Correlation Between Hospital Rates of Survival to Discharge and Long-Term Survival for In-Hospital Cardiac Arrest: Insights from Get With The Guidelines®- Resuscitation
Paul S. Chan, MD; Kevin Kennedy

12:15 – 1 p.m. 
Outcomes of Left Atrial Appendage Occlusion in Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
Kevin Kennedy; Chetan P. Huded, MD

2:15 – 3 p.m.
Ruptured Coronary Mycotic Aneurysm Caused by MSSA Bacteremia
Raul Angel Garcia, MD; Mohammed Saghir, MD

2:15 – 3 p.m.
Predictors of Bleeding in Stemi Patients Who Underwent Trans-Radial Percutaneous Coronary Intervention
Chetan P. Huded, MD

3:15 – 4 p.m.
Diagnosis of Acute Aortic Dissection Through Left Ventriculogram
Raul Angel Garcia, MD; Dan Nguyen, MD

3:45 – 3:55 p.m.
Survival Outcomes for Asian and Hispanic Patients with In-Hospital Cardiac Arrest: An Analysis From Get With the Guidelines® - Resucitation 
Charles Sherrod, MD; Mirza S. Khan, MD; Nobuhiro Ikemura, MD; Kevin Kennedy; Paul S. Chan, MD

Monday, April 8

8:53 – 9:03 a.m.
Efficacy and Safety of the Agent Paclitaxel-Coated Balloon in Multi-Layer In-Stent Restenosis – A Subgroup Analysis of the AGENT IDE Randomized Trial
James Aaron Grantham, MD

9:45 – 9:55 a.m.
Lack of Hemodynamic Response to Vasodilator Stress is Associated with Cardiovascular Events
Timothy M. Bateman

10:15 – 10:25 a.m.
Early Improvement in Quality of Life with Percutaneous Coronary Intervention Versus Medical Therapy in Severe Ischemic Ventricular Dysfunction: Data from the REVIVED-BCIS2 Randomized Trial
Mikhail Kosiborod, MD; John A. Spertus, MD

10:45 – 11:30 a.m.
Relationship Between Inflammatory Biomarkers and Outcomes: An Analysis from DEFINE-HF
Charles Sherrod, MD; Andrew Sauer, MD; Shachi Patel; Sheryl Windsor; Michael Nassif, MD; Bethany A. Austin, MD; Mikhail Kosiborod, MD

11 – 11:10 a.m.
Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report from the STS/ACC TVT Registry
Suzanne Arnold, MD

11:30 – 11:40 a.m.
Physician Wellness: From Concept to Reality
Andrew Sauer, MD

3:15 – 3:30 p.m.
How to Set Up A Multidisciplinary Clinic For Device Management of Heart Failure Patients
Andrew Sauer, MD

3:28 – 3:38 p.m.
Cardiac Rehab and the Role in SIHD
Suzanne Arnold, MD

Saint Luke's Panelists and Moderators

Saturday, April 6

Noon – 1:15 p.m.
Coronary Intervention in the Complex Patient: Strategies For Success
James Aaron Grantham, MD

1:30 – 3 p.m.
From Genes to Molecular Causes of Heart Failure 
Andrew Sauer, MD

1:45 – 3 p.m.
Iconic Debates in Cardiac Imaging: Translating the Current Evidence Into Clinical Practice
John A. Spertus, MD

Monday, April 8

8:30 – 9:45 a.m.
I'm Having a Bad Leg Day: Complications of Peripheral Vascular Interventions 
Matthew C. Bunte, MD

2:30 – 3:45 p.m.
Sharing the Sandbox: The Importance of Collaboration Between EP and HF
Andrew Sauer, MD

For a complete list of presentations, visit the American College of Cardiology Scientific Session website.

Industry-Leading Clinical Research

Clinical research is the foundation for improving patient care. Saint Luke’s uses leading-edge research to advance cardiovascular medicine, always with the goal of benefiting the patient, continuously striving to improve outcomes, and improve patients' quality of life.

Advancing Cardiovascular Medicine

At Saint Luke’s Mid America Heart Institute, our research programs span multiple key areas, including cardiac transplantation, electrophysiology, cardiac imaging, preventative cardiology, and cardiometabolic disease.

In addition to supporting clinical research, Saint Luke's has centers of cardiovascular excellence and core laboratories in cardiovascular outcomes and cardiometabolic research; health economics and technology assessment; intravascular imaging; and noninvasive imaging.

Our program is truly comprehensive, from preventive care to treating the most complex and serious conditions.

A Leader in Cardiovascular Research

In recent years, Saint Luke’s researchers have annually published more than 300 peer-reviewed scientific articles in well-respected medical journals such as the New England Journal of Medicine, Journal of American Medical Association, The Lancet, Circulation, and the Journal of the American College of Cardiology.

The Heart Institute serves as one of four designated data analytic centers for the American College of Cardiology and the National Cardiovascular Data Registry, and is leading multiple global trials across different therapeutic areas.

Significant Accomplishments in Research

Actively involved in more than 100 clinical trials 

Pioneers in Interventional Cardiology

• First Balloon Angioplasty
• First Transcatheter Aortic Valve Replacement (TAVR) in Midwest 
• Leaders in Complex Coronary interventions 

Developed the international standards for quantifying patient-centered outcomes

• Development of the Kansas City Cardiomyopathy Questionnaire
• Development of the Seattle Angina Questionnaire
• Development of the Peripheral Artery Questionnaire

International, practice-changing ISCHEMIA Trial

Leaders in the field of Cardiometabolic Disease

• Led STEP-HFpEF, the first trial to target obesity as a treatment for heart failure, which was named as a scientific breakthrough of the year by Science Magazine, and one of the top articles by the New England Journal of Medicine in 2023
• Leading the Design and Execution of numerous clinical trials of SGLT2 inhibitors with impact for international guidelines and clinical practice: DEFINE HF, PRESERVED HF 
• EMBRACE-HF, DAPA-HF, DELIVER, EMPULSE
• DARE-19
• Cardiometabolic Center of Excellence, and Cardiometabolic Center Alliance
• First-of-a-kind decentralized trial (CHIEF-HF)

Educating the next generation of clinicians and investigators

• Advanced fellowships in all domains of cardiology
• NIH-funded T32 in Cardiovascular Quality and Outcomes Research
• Ben McCallister, MD Clinical Scholar Program

About Saint Luke’s Mid America Heart Institute

Saint Luke’s Mid America Heart Institute offers some of the most comprehensive heart and vascular care in the nation. Ranked in the top 50 in the nation for Cardiology, Vascular & Heart Surgery by U.S. News & World Report, the experts at the Heart Institute use the latest technology, research, and innovations to treat the full range of cardiovascular services, from disease prevention to heart transplantation.

With more specialized physicians, more experience, and more innovative treatment options, the Heart Institute is the third hospital in the U.S. to achieve Comprehensive Cardiac Center certification from The Joint Commission. Saint Luke's is proud to help advance cardiovascular care in the nation.